Moxonidine for Hypertension in Metabolic Syndrome

Moxonidine for Hypertension in Metabolic Syndrome

The centrally acting antihypertensive, moxonidine, reduces blood pressure (BP) in mild-to-moderate hypertensive patients as effectively as most first-line antihypertensives when used as monotherapy, and also in combination with other antihypertensive agents. It improves the metabolic profile in patients with hypertension and diabetes mellitus or impaired glucose tolerance, is well tolerated, has a low potential for drug interactions and may be administered once daily in most patients.
 

Modern Medicine – Issue 3 2021

Glycosaminoglycan Replacement Targets Painful Bladder

Glycosaminoglycan Replacement Targets Painful Bladder

Interstitial cystitis/bladder pain syndrome (IC/BPS) is a debilitating chronic disease characterised by discomfort or recurrent abdominal and pelvic pains in the absence of urinary tract infections. Although the aetiology is unknown, there is increasing evidence that increased bladder layer permeability is linked to the symptoms of interstitial cystitis or painful bladder.

Modern Medicine – Issue 3 2021

Towards Definitive Management of Allergic Rhinitis Best use of new and established therapies

Towards Definitive Management of Allergic Rhinitis
Best use of new and established therapies

Allergic rhinitis (AR) is an inflammatory disease of the nasal mucosa impacting almost 25% of Canadians and up to 38.5% of South Africans. The standard of care for AR includes a treatment plan that takes into account patient preferences, the severity of the disease, and most essentially involves a shared decision-making process between patient and provider. This is a shortened version of the original open access article.

Modern Medicine – Issue 3 2021

Unpacking the Mind-body Connection to Health

Unpacking the Mind-body Connection to Health

“According to the mind–body or biopsychosocial paradigm, which supersedes the older biomedical model, there is no real division between mind and body because of networks of communication that exist between the brain and neurological, endocrine and immune systems.” – Oakley Ray, Professor Emeritus of Psychology, Psychiatry and Pharmacology at Vanderbilt University, USA.

Modern Medicine – Issue 3 2021

Modern Medicine – Issue 2, 2021

The latest edition of Modern Medicine is now available for you to read. We have some great articles featured in this edition to give you something to read over the easter break period; topics covered include:​

  • Ethics (CPD) – Commoditisation in Healthcare
  • Pulmonology (CPD) – Paediatric Asthma
  • Cardiology – 2020 Heart Failure Guidelines
  • Gastroenterology (CPD) – Is It IBD?
  • … and many more !

Also, a reminder that, not only do we have CPD questions available within the magazine itself, we also have an online CPD portal that allows you to score even more points by simply completing your test online

Modern Medicine, the journal that’s with you wherever you go.

Pre-eclampsia Prediction and Prevention is Key

Pre-eclampsia Prediction and Prevention is Key

Pre-eclampsia (PE) is a complex pregnancy disease that affects the safety of 3% to 5% of pregnancies worldwide and is one of the important causes of maternal, foetal and neonatal deaths. To date, the pathogenesis of PE is not yet clear. Due to the lack of specific effective treatments for PE, its prediction and prevention are particularly important.

Modern Medicine – Issue 2 2021